BOSTON (AP) — The CEO of a hospital operator that filed for chapter safety in Could will step down after failing to testify earlier than a U.S. Senate panel.

Steward Well being Care CEO Ralph de la Torre has overseen a community of some 30 hospitals across the nation. The Texas-based firm’s troubled recent history has drawn scrutiny from elected officers in New England, the place a few of its hospitals are situated.

A spokesperson for de la Torre stated Saturday that he “has amicably separated from Steward on mutually agreeable phrases” and “will proceed to be a tireless advocate for the advance of reimbursement charges for the underprivileged affected person inhabitants.”

Vermont U.S. Sen. Bernie Sanders, who chairs the Senate Well being, Schooling, Labor and Pensions Committee, stated earlier this month that Congress “will hold Dr. de la Torre accountable for his greed and for the harm he has prompted to hospitals and sufferers all through America.”

De la Torre’s resignation is efficient Oct. 1. The Senate accepted a decision on Wednesday that was meant to hold him in criminal contempt for failing to testify earlier than a committee.

The Senate panel has been wanting into Steward’s chapter. De la Torre didn’t seem earlier than it regardless of being issued a subpoena. The decision refers the matter to a federal prosecutor.

Earlier than you make your subsequent commerce, you may need to hear this.

MarketBeat retains observe of Wall Road’s top-rated and greatest performing analysis analysts and the shares they suggest to their purchasers each day.

Our workforce has recognized the 5 shares that prime analysts are quietly whispering to their purchasers to purchase now earlier than the broader market catches on… and not one of the massive title shares have been on the checklist.

They consider these 5 shares are the 5 greatest firms for buyers to purchase now…

See The 5 Shares Right here

Click on the hyperlink under and we’ll ship you MarketBeat’s checklist of the ten greatest shares to personal in 2024 and why they need to be in your portfolio.

Get This Free Report

Like this text? Share it with a colleague.

Hyperlink copied to clipboard.



Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *